Back to Search
DAVID VANDERWEELE, M.D.
M.D.
Medical Oncology Physician
NPI: 1689846834IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 2007
Research & Publications (7)
Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate.
PMID 16317089·Mol Cancer Res·2005
7-preclinical
Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin.
PMID 15634654·Mol Cancer Ther·2004
7-preclinical
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
PMID 18978206·Blood·2009
8-other
Svf1 inhibits reactive oxygen species generation and promotes survival under conditions of oxidative stress in Saccharomyces cerevisiae.
PMID 16034825·Yeast·2005
7-preclinical
No relationship between sequence variation in protein coding regions of the Tas1r3 gene and saccharin preference in rats.
PMID 15741599·Chem Senses·2005
7-preclinical
Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
PMID 12543781·Cancer Res·2003
8-other
Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism.
PMID 12244097·J Biol Chem·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 10 Center Dr
Bethesda, MD 20892 - Phone
- (301) 319-2919
Quick Facts
- NPI
- 1689846834
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 19
- Publications
- 7
Are you this provider?
Claim Your Profile